ARV-393 is a PROTAC degrader targeting BCL6 with the advantage of being highly potent and orally available.ARV-393 recruits BCL6 and E3 ligase cerebellum to rapidly degrade BCL6 through the cells natural ubiquitin proteasome system for the treatment of diffuse large b-cell lymphoma (DLBCL) and non-Hodgkins lymphoma (NHL).
Molecular Weight:
898.42
Purity:
99.96%
CAS Number:
[2851885-95-3]
Formula:
C46H53ClFN9O7
Target:
PROTACs|||Bcl-6
T84316
* VAT and and shipping costs not included. Errors and price changes excepted